Ambrish Singh Email
Associate Director | HEOR Evidence Synthesis @ Eli Lilly and Company
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Ambrish Singh Location
- India
Ambrish Singh Work
- 2025 -now Associate Director | HEOR Evidence Synthesis @ Eli Lilly and Company
- 2024 -now Associate Editor @ Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- 2025 -now Associate Editor @
- 2023 -now Adjunct Researcher @
- 2022 -2025 Scientist - HEOR | HTA | RWE @ Eli Lilly and Company
- 2021 -2022 Health Economics and Policy Consultant @
- 2019 -2021 Consultant — Global Health Economics and Outcome Research @ Global | Contractual | Freelance | Project execution
- 2018 -2019 Senior Associate Manager — Global Patient Outcome and Real World Evidence @ Eli Lilly and Company
- 2015 -2018 Specialist-Market Access — Healthcare Economics and Reimbursement @
- 2014 -2015 Sr. Research Analyst — Health Economics and Outcome Research @
- 2012 -2014 Pharmacovigilance Scientist @
- 2011 -2012 Management Executive @
- 2005 -2006 Scientific Promotion Executive @
Ambrish Singh Education
- University of Tasmania
Doctor of Philosophy - PhD
2019-2022 - University of Melbourne
Practical Methods for Health Economic Evaluation
2021-2021 - Indian Institutes of Public Health (IIPHs)
PG Diploma
2014-2015 - ANNA UNIVERSITY - India
Master of Technology
2009-2011 - Dr. A.P.J. Abdul Kalam Technical University
Bachelor of Pharmacy - BPharm
2006-2009 - Delhi Pharmaceutical Sciences and Research University (DPSRU)
Diploma
2003-2005
Ambrish Singh Skills
- Medical Writing
- Systematic Reviews
- Pharmacoeconomics
- Publications
- Clinical Research
- Health Technology Assessment (HTA)
- Pharmaceutical Industry
- Biotechnology
- Clinical Trials
- Pharmacovigilance
- Data Analysis
- Medical Devices
- Market Access
- Pharmacology
- Biostatistics
- Pricing Strategy
- Health Economics
- Patient Safety
- Outcome Research
- Good Clinical Practice (GCP)
Ambrish Singh Summary
- Ambrish Singh, based in India, is currently a Associate Director | HEOR Evidence Synthesis at Eli Lilly and Company. Ambrish Singh brings experience from previous roles at Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Egyptian Rheumatology and Rehabilitation Journal, Menzies Institute for Medical Research and Eli Lilly and Company. Ambrish Singh holds a 2019 - 2022 Doctor of Philosophy - PhD @ University of Tasmania. With a robust skill set that includes Medical Writing, Systematic Reviews, Pharmacoeconomics, Publications, Clinical Research and more. Ambrish Singh has 5 emails on RocketReach.
Looking for a different Ambrish Singh?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co